Mark E. Jones

发表

Multidrug-Resistant Urinary Tract Isolates ofEscherichia coli: Prevalence and Patient Demographics in the United States in 2000

Clyde Thornsberry, J. Karlowsky, D. Sahm, 2001, Antimicrobial Agents and Chemotherapy.

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network.

A. Evangelista, J. Karlowsky, D. Sahm, 2002, International journal of antimicrobial agents.

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997

J. Verhoef, A. Fluit, Mark E. Jones, 2000, Antonie van Leeuwenhoek.

Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

J. Karlowsky, D. Sahm, Mark E. Jones, 2002, Antimicrobial Agents and Chemotherapy.

Drug‐drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4

A. Groll, M. Engelhardt, Mark E. Jones, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Antimicrobial Agents and Chemotherapy.

Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.

A. Evangelista, J. Karlowsky, D. Sahm, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Four Antimicrobial Susceptibility Testing Methods To Determine the In Vitro Activities of Piperacillin and Piperacillin-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Journal of Clinical Microbiology.

Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial

V. Fowler, H. Seifert, T. Holland, 2020, Future microbiology.

Clinical Isolates of Streptococcus pneumoniae with Different Susceptibilities to Ceftriaxone and Cefotaxime

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Antimicrobial Agents and Chemotherapy.

Longitudinal Assessment of Antipneumococcal Susceptibility in the United States

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

J. Karlowsky, D. Sahm, I. Critchley, 2001, Antimicrobial Agents and Chemotherapy.

Benchmarking the In Vitro Activities of Moxifloxacin and Comparator Agents against Recent Respiratory Isolates from 377 Medical Centers throughout the United States

D. Sahm, I. Critchley, Mark E. Jones, 2000, Antimicrobial Agents and Chemotherapy.

Emergence and Spread in French Hospitals of Methicillin-Resistant Staphylococcus aureus with Increasing Susceptibility to Gentamicin and Other Antibiotics

F. Vandenesch, G. Lina, V. Jarlier, 1999, Journal of Clinical Microbiology.

Ty p i n g of m et h i ci I I i n -resist a n t Staph ylococcus aureus isolates from Dusseldorf by six genotypic methods

K. Köhrer, M. Steiert, Heinrich-Heine-Universitat Dusseldorf, 1998 .

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003

J. Karlowsky, D. Sahm, Mark E. Jones, 2004, Annals of Clinical Microbiology and Antimicrobials.

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)

S. Simeonov, D. Ionescu, K. Hamed, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

J. Karlowsky, D. Sahm, Mark E. Jones, 2004, Annals of Clinical Microbiology and Antimicrobials.

In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy

R. Wenzel, J. Karlowsky, D. Sahm, 2003, Antimicrobial Agents and Chemotherapy.

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

A. Evangelista, J. Karlowsky, D. Sahm, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001

J. Karlowsky, D. Sahm, I. Critchley, 2003, Antimicrobial Agents and Chemotherapy.

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

A. Evangelista, J. Karlowsky, D. Sahm, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.

J. Karlowsky, D. Sahm, I. Critchley, 2003, The Journal of antimicrobial chemotherapy.

In Vitro Activities of Broad-Spectrum Cephalosporins against Nonmeningeal Isolates of Streptococcus pneumoniae: MIC Interpretation Using NCCLS M100-S12 Recommendations

J. Karlowsky, D. Sahm, Mark E. Jones, 2002, Journal of Clinical Microbiology.

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.

J. Karlowsky, D. Sahm, I. Critchley, 2002, International journal of antimicrobial agents.

Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.

J. Karlowsky, D. Sahm, I. Critchley, 2002, International journal of antimicrobial agents.

Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002

J. Karlowsky, D. Sahm, R. Flamm, 2004, Antimicrobial Agents and Chemotherapy.

Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States

G. Noel, A. Evangelista, J. Karlowsky, 2003, Antimicrobial Agents and Chemotherapy.

Towards better surveillance of bacterial antibiotic resistance.

Mark E. Jones, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

Antimicrobial resistance among community-acquired pneumonia isolates in Europe: First results from the SENTRY antimicrobial surveillance program 1997

J. Verhoef, A. Fluit, Mark E. Jones, 1999 .

Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.

J. Karlowsky, D. Sahm, I. Critchley, 2002, International journal of antimicrobial agents.

Differences Between Ceftriaxone and Cefotaxime: Microbiological Inconsistencies

J. Gums, Mark E. Jones, R. Sanderson, 2008, The Annals of pharmacotherapy.

Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates ofStreptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season

K. Köhrer, P. Heisig, D. Sahm, 2000, Antimicrobial Agents and Chemotherapy.

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

Relationship between Antibiotic Resistance in Streptococcus pneumoniae and That in Haemophilus influenzae: Evidence for Common Selective Pressure

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Diagnostic microbiology and infectious disease.

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

M. Ghannoum, P. Mukherjee, D. Andes, 2018, Antimicrobial Agents and Chemotherapy.

Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P 450 3 A 4

M. Engelhardt, Mark E. Jones, N. Azie, 2017 .

Many Class I Integrons Comprise Distinct Stable Structures Occurring in Different Species ofEnterobacteriaceae Isolated from Widespread Geographic Regions in Europe

J. Verhoef, F. Schmitz, A. Fluit, 1999, Antimicrobial Agents and Chemotherapy.

Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002

J. Karlowsky, J. Bradley, D. Sahm, 2004, Annals of Clinical Microbiology and Antimicrobials.

Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.

J. Karlowsky, D. Sahm, I. Critchley, 2003, The Journal of antimicrobial chemotherapy.

Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureu

M. Visser, J. Verhoef, P. Heisig, 1999, Antimicrobial Agents and Chemotherapy.

Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release

J. Karlowsky, D. Sahm, I. Critchley, 2002, Antimicrobial Agents and Chemotherapy.

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

D. Nathwani, J. Karlowsky, D. Sahm, 2003, International journal of antimicrobial agents.

Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

M. Neely, G. McComsey, T. Walsh, 2021, Antimicrobial agents and chemotherapy.

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Antimicrobial Agents and Chemotherapy.

P1676 Evaluation of isavuconazole (BAL8557/BAL4815) Etest compared to broth microdilution antifungal susceptibility testing against quality control strains and fluconazole-susceptible clinical Candida isolates

D. Sahm, M. Heep, Mark E. Jones, 2007 .

Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria

J. Verhoef, A. Fluit, Mark E. Jones, 1997, The Lancet.

Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility

R. Wenzel, J. Karlowsky, D. Sahm, 2022 .

Characterization of grlA, grlB, gyrA, and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MIC

K. Köhrer, J. Verhoef, A. Fluit, 1998, Antimicrobial Agents and Chemotherapy.

'Neisseria gonorrhoea' testing in New Zealand, culture or PCR?

Amanda Miller, Mark E. Jones, Collette Bromhead, 2013 .

Comparison of the cobas 4800 CT/NG Test with Culture for Detecting Neisseria gonorrhoeae in Genital and Nongenital Specimens in a Low-Prevalence Population in New Zealand

D. Whiley, C. Bromhead, Mark E. Jones, 2013, Journal of Clinical Microbiology.

Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicillin-Resistant Strain

J. Karlowsky, D. Sahm, I. Critchley, 2002, Journal of Clinical Microbiology.

Prevalence of Molecular Types andmecA Gene Carriage of Coagulase-Negative Staphylococci in a Neonatal Intensive Care Unit: Relation to Nosocomial Septicemia

T. Krediet, A. Fleer, Mark E. Jones, 2001, Journal of Clinical Microbiology.

Clinical Characteristics of Bloodstream Infections Due to Ampicillin-Sulbactam-Resistant, Non-Extended-Spectrum- (cid:1) -Lactamase-Producing Escherichia coli and the Role of TEM-1 Hyperproduction (cid:1)

D. Paterson, K. Shutt, Z. Qureshi, 2011 .

Factors influencing fluoroquinolone resistance.

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Emerging infectious diseases.

The stability of grlA, grlB, gyrA, gyrB and norA mutations and MIC values of five fluoroquinolones in three different clonal populations of methicillin-resistant Staphylococcus aureus.

K. Köhrer, J. Verhoef, A. Fluit, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Activity of cefditoren against beta-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis.

J. Karlowsky, D. Sahm, I. Critchley, 2002, Diagnostic microbiology and infectious disease.

Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.

D. Sahm, Mark E. Jones, C. Thornsberry, 2008, Postgraduate medicine.

Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.

M. Tunney, R. Cantón, A. Fluit, 2019, International journal of antimicrobial agents.

Prevalence of Oxacillin Resistance in Staphylococcus aureus among Inpatients and Outpatients in the United States during 2000

J. Karlowsky, D. Sahm, Mark E. Jones, 2002, Antimicrobial Agents and Chemotherapy.

Antibiotic Sensitivity of Penicillin - Resistant Staphylococcus aureus in three midwestern family practice populations

Mark E. Jones, D. Helling, S. Massad, 1980 .

The Activity of Levofloxacin and Comparator Agents against Clinical Isolates of Streptococcus pneumoniae Collected Worldwide during 1999 and 2000

J. Karlowsky, D. Sahm, I. Critchley, 2002, Chemotherapy.

The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.

J. Verhoef, A. Fluit, B. Hofmann, 1998, The Journal of antimicrobial chemotherapy.

Antimicrobial susceptibility of coagulase-negative staphylococci isolated between 1991 and 1996 from a German university hospital.

J. Verhoef, A. Fluit, H. Heinz, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

M. Ghannoum, P. Mukherjee, D. Andes, 2018, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.

J. Verhoef, F. Schmitz, A. Fluit, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

M. Jones, D. Sahm, Mark E. Jones, 1999, The Journal of antimicrobial chemotherapy.

Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?

M. Jones, Mark E. Jones, F. Schmitz, 1997, International journal of antimicrobial agents.

Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.

T. Krediet, A. Fleer, M. Jones, 1999, Pediatrics.

Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.

J. Verhoef, F. Schmitz, A. Fluit, 1998, The Journal of antimicrobial chemotherapy.

The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.

J. Verhoef, F. Schmitz, A. Fluit, 1999, The Journal of antimicrobial chemotherapy.

Annals of Clinical Microbiology and Antimicrobials Open Access Prevalence and Antimicrobial Susceptibilities of Bacteria Isolated from Blood Cultures of Hospitalized Patients in the United States in 2002

J. Karlowsky, D. Sahm, Mark E. Jones, 2022 .

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.

A. Evangelista, J. Karlowsky, M. Jones, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).

G. Tillotson, M. Jones, D. Sahm, 2006, International journal of antimicrobial agents.

Factors influencing fluoroquinolone resistance.

J. Karlowsky, D. Sahm, Mark E. Jones, 2003, Emerging infectious diseases.

Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network (TSN) Database-USA.

J. Karlowsky, M. Jones, D. Sahm, 2002, International journal of antimicrobial agents.

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.

J. Karlowsky, M. Jones, D. Sahm, 2001, International journal of antimicrobial agents.

Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods.

K. Köhrer, M. Steiert, J. Verhoef, 1998, Journal of medical microbiology.

Annals of Clinical Microbiology and Antimicrobials Prevalence of Antimicrobial Resistance in Bacteria Isolated from Central Nervous System Specimens as Reported by U.s. Hospital Laboratories from 2000 to 2002 Central Nervous System Infectionsmeningitisantibiotic Susceptibility

J. Karlowsky, Mark E. Jones, Deborah C. Draghi, 2022 .

Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study.

M. Jones, D. Sahm, I. Critchley, 2000, Diagnostic microbiology and infectious disease.

The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

D. Sahm, I. Critchley, Mark E. Jones, 1999, Drugs.

R. Wenzel, J. Karlowsky, D. Sahm, 2022 .

Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.

K. Köhrer, J. Verhoef, A. Fluit, 1998, The Journal of antimicrobial chemotherapy.